Tag Archives for " Bayer "

Looking beyond central bank interference in equity valuations

Behind the incessant background noise of Yellen’s ‘will she won’t she raise rates’ discussion, the closing of the Q1 results season provides a good opportunity to take stock of the broader earnings and more importantly OpFCF yield basis on which equities are priced. Relative to expectations at the start of the year, there have been […]

Continue reading